Evans Desrosiers

Array ( [id] => 3123808 [patent_doc_number] => 05436232 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-25 [patent_title] => 'Pharmaceutical composition for peritoneal dialysis' [patent_app_type] => 1 [patent_app_number] => 8/178537 [patent_app_country] => US [patent_app_date] => 1994-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2657 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/436/05436232.pdf [firstpage_image] =>[orig_patent_app_number] => 178537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3478084 [patent_doc_number] => 05456912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-10 [patent_title] => 'Non-methylene interrupted fatty acids as immunomodulators' [patent_app_type] => 1 [patent_app_number] => 8/174956 [patent_app_country] => US [patent_app_date] => 1993-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7595 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/456/05456912.pdf [firstpage_image] =>[orig_patent_app_number] => 174956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589848 [patent_doc_number] => 05496801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Parathyroid hormone formulation' [patent_app_type] => 1 [patent_app_number] => 8/172206 [patent_app_country] => US [patent_app_date] => 1993-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3868 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496801.pdf [firstpage_image] =>[orig_patent_app_number] => 172206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3487638 [patent_doc_number] => 05474985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/171448 [patent_app_country] => US [patent_app_date] => 1993-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10443 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474985.pdf [firstpage_image] =>[orig_patent_app_number] => 171448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3443656 [patent_doc_number] => 05430155 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => '1,4-diamine-2,3-dihydroxy butanes' [patent_app_type] => 1 [patent_app_number] => 8/167659 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41571 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/430/05430155.pdf [firstpage_image] =>[orig_patent_app_number] => 167659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3114167 [patent_doc_number] => 05409907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Aqueous pharmaceutical suspension for pharmaceutical actives' [patent_app_type] => 1 [patent_app_number] => 8/168605 [patent_app_country] => US [patent_app_date] => 1993-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4883 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/409/05409907.pdf [firstpage_image] =>[orig_patent_app_number] => 168605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3484273 [patent_doc_number] => 05474759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Non-chlorofluorocarbon aerosol formulations' [patent_app_type] => 1 [patent_app_number] => 8/157182 [patent_app_country] => US [patent_app_date] => 1993-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3518 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474759.pdf [firstpage_image] =>[orig_patent_app_number] => 157182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3425858 [patent_doc_number] => 05416075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-16 [patent_title] => 'Biospecific emulsions' [patent_app_type] => 1 [patent_app_number] => 8/159994 [patent_app_country] => US [patent_app_date] => 1993-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8830 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/416/05416075.pdf [firstpage_image] =>[orig_patent_app_number] => 159994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3415330 [patent_doc_number] => 05433956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Sol gel composition for producing glassy coatings' [patent_app_type] => 1 [patent_app_number] => 8/142487 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6487 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/433/05433956.pdf [firstpage_image] =>[orig_patent_app_number] => 142487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3415114 [patent_doc_number] => 05433941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Sol gel composition for producing glassy coatings' [patent_app_type] => 1 [patent_app_number] => 8/142486 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8178 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/433/05433941.pdf [firstpage_image] =>[orig_patent_app_number] => 142486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3451066 [patent_doc_number] => 05451409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-19 [patent_title] => 'Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends' [patent_app_type] => 1 [patent_app_number] => 8/156223 [patent_app_country] => US [patent_app_date] => 1993-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4551 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/451/05451409.pdf [firstpage_image] =>[orig_patent_app_number] => 156223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552981 [patent_doc_number] => 05492911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-20 [patent_title] => 'Linsidomine for the treatment for erectile dysfunctions' [patent_app_type] => 1 [patent_app_number] => 8/146204 [patent_app_country] => US [patent_app_date] => 1993-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3287 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/492/05492911.pdf [firstpage_image] =>[orig_patent_app_number] => 146204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458226 [patent_doc_number] => 05468499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-21 [patent_title] => 'Liposomes containing the salt of phosphoramide mustard and related compounds' [patent_app_type] => 1 [patent_app_number] => 8/152493 [patent_app_country] => US [patent_app_date] => 1993-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4310 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/468/05468499.pdf [firstpage_image] =>[orig_patent_app_number] => 152493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3490239 [patent_doc_number] => 05439894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-08 [patent_title] => 'Dextrin derivatives for the treatment of acidic conditions' [patent_app_type] => 1 [patent_app_number] => 8/150717 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2042 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/439/05439894.pdf [firstpage_image] =>[orig_patent_app_number] => 150717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3410909 [patent_doc_number] => 05438067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Medetomidine preparations for transdermal administration' [patent_app_type] => 1 [patent_app_number] => 8/146201 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3168 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/438/05438067.pdf [firstpage_image] =>[orig_patent_app_number] => 146201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3567107 [patent_doc_number] => 05484776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration' [patent_app_type] => 1 [patent_app_number] => 8/135992 [patent_app_country] => US [patent_app_date] => 1993-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2764 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484776.pdf [firstpage_image] =>[orig_patent_app_number] => 135992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3448940 [patent_doc_number] => 05424300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-13 [patent_title] => 'Method for treatment of chronic fatigue syndrome' [patent_app_type] => 1 [patent_app_number] => 8/135347 [patent_app_country] => US [patent_app_date] => 1993-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2787 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/424/05424300.pdf [firstpage_image] =>[orig_patent_app_number] => 135347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3442272 [patent_doc_number] => 05430065 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => 'Therapeutical method for enhancing peripheral glucose utilization in a non-insulin-dependent diabetic patient' [patent_app_type] => 1 [patent_app_number] => 8/132817 [patent_app_country] => US [patent_app_date] => 1993-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1939 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/430/05430065.pdf [firstpage_image] =>[orig_patent_app_number] => 132817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3429495 [patent_doc_number] => 05403927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-04 [patent_title] => 'Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/134101 [patent_app_country] => US [patent_app_date] => 1993-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19534 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/403/05403927.pdf [firstpage_image] =>[orig_patent_app_number] => 134101 [rel_patent_id] =>[rel_patent_doc_number] =>)